(2R,3R)-2-Methyl-3-((methylsulfonyl)methyl)azetidine hydrochloride, 98%, 5g

acide ortho-phosphorique 75%, 75%, extra pur, 2,5 l, emballage plastique.

1,2,3,4-Cyclopentanetetracarboxylic Dianhydride (purified by sublimation)>99.0%(T)5g

2-Phenoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

Methyl 3-(hydroxymethyl)benzoate, 95.0%, 5g

Sapitinib, 99.93%, 5mg

Azido-PEG1-azide, 100mg

5-Methyl-1-(oxan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 97%, 250mg

(3-Chloro-2-nitrophenyl)methanol, 95.0%, 1g

Bicyclo[3.2.1]oct-2-ene>98.0%(GC)1g

1,4-DIMETHYLPYRIDINIUM IODIDE, 95%, 10g

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 97.0%, 5g

ETHYL 3-CHLORO-1H-PYRAZOLE-5-CARBOXYLATE, 95.0%, 5g